Another important pathogenic aspect of AD is the disturbance of the blood–brain barrier (BBB), and recent studies have shown that degradation of the BBB pericytes contributes to neurovascular dysfunction and exacerbation of Aβ and tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.